Publications of Sven Göbel

Talk (13)

21.
Talk
Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Intensified cell-based virus production: A process development challenge for multiple cell-virus combinations. 16th PEACe Conference, Sitges (Spain) (2023)
22.
Talk
Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Next-Generation Virus Production: From Clone, to AMBR, to Perfusion and Very High Virus Yield. International Society for Vaccines (ISV) Annual Congress, Lausanne (Switzerland) (2023)
23.
Talk
Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Increase in supply through use of new technologies for high yield vaccines. Flanders Vaccine, Brussels (Belgium) (2023)
24.
Talk
Göbel, S.; Dallmeier, K.; Jordan, I.; de Jong, J.; Reichl, U.; Genzel, Y.: Intensified production for a yellow fever - ZIKA virus vaccine candicate. Democratization of biotherapies: new manufacturing modalities and intensification's, Oxford, UK (2023)
25.
Talk
Göbel, S.; Jaén, K. E.; Pelz, L.; Reiter , M.; Altomonte, J.; Reichl, U.; Genzel, Y.: Intensifiying OSB processes for high titer virus production. 5th large scale meeting: Orbital shaken bioreactors, Girona (Spain) (2023)
26.
Talk
Göbel, S.; Pelz, L.; Behrendt, I.; Prömmel, M.; Altomonte, J.; Anderlei, T.; Bürgin, T.; Genzel, Y.; Reichl, U.: Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus production. Single-Use Technologies V: Building the Future, Marseille, France (2022)
27.
Talk
Gränicher, G.; Göbel, S.; Marichal-Gallardo, P.; Jordan, I.; Sandig, V.; Genzel, Y.; Reichl, U.: Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. Value through intensified bioprocessing II, Oxford, United Kingdom (2022)
28.
Talk
Gränicher, G.; Göbel, S.; Marichal-Gallardo, P.; Jordan, I.; Sandig, V.; Genzel, Y.; Reichl, U.: Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. 27th ESACT Meeting, Lisbon (Portugal) (2022)

Poster (8)

29.
Poster
Lang, C.; Findley, R.; Winfree, B.; Otsuka, Y.; Göbel, S.; Spicer, T.; Boisvert, M.; Bilem, I.; Goldberg, I.: Advanced sensors for automation of online and inline assays in biomanufacturing using imaging and AI. NIIMBL National Meeting, Washington D.C. (USA) / virtually (2025)
30.
Poster
Göbel, S.; Kazemi, O.; Jordan, I.; Dallmeier, K.; Reichl, U.; Genzel, Y.: Multifactorial highthroughput process screening for a yellow-fever virus vectored Zika vaccine candidate. Vaccine Technology IX, Los Cabos (Mexico) (2024)
31.
Poster
Göbel, S.; Pelz, L.; Silva, C.; Brühlmann, B.; Hill, C.; Altomonte, J.; Kamen, A.; Reichl, U.; Genzel, Y.: Intensified production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. 28th ESACT Meeting, Edingburgh (Scotland) (2024)
32.
Poster
Jacobtorweihe, L.; Göbel, S.; Wolschek, M.; Altomonte, J.; Reichl, U.; Genzel, Y.: HCD Perfusion of CCX.E10 Quail Cells for Production of Vesicular Stomatitis Virus based oncolytic Vaccine. Vaccine Technology IX, Los Cabos (Mexico) (2024)
33.
Poster
Jacobtorweihe, L.; Göbel, S.; Wolschek, M.; Altomonte, J.; Reichl, U.; Genzel, Y.: Production of Oncolytic rVSV-NDV in CCX.E10 Quail Cells by HCD Perfusion Culture. Himmelfahrtstagung on Bioprocess Engineering 2024, Regensburg (Germany) (2024)
34.
Poster
Göbel, S.; Dorn, M.; Jaén Chavez, K.; Jordan, I.; Sandig, V.; Altomonte, J.; Genzel, Y.; Reichl, U.: Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processes. Vaccine Technology VIII, Sitges (Spain) (2022)
35.
Poster
Göbel, S.; Jordan, I.; Sandig, V.; Altomonte, J.; Genzel, Y.; Reichl, U.: Towards the production of a fusogenic oncolytic rVSV-NDV virus in perfusion mode. 27th ESACT Meeting, Lisbon (Portugal) (2022)
36.
Poster
Göbel, S.; Kortum, F.; Jaén Chavez, K.; Jordan, I.; Sandig, V.; Altomonte, J.; Genzel, Y.; Reichl, U.: Production of a fusogenic oncolytic VSV-NDV virus: cell-line screening and process development in small-scale suspension cultures. Advancing Manufacture of Cell and Gene Therapies VII, Coronado, CA (USA) (2022)

Thesis - PhD (1)

37.
Thesis - PhD
Göbel, S.: Production of a fusogenic oncolytic virus: In-depth process development and process intensification. Dissertation, Otto-von-Guericke-Universität, Magdeburg (2024)

Preprint (1)

38.
Preprint
Gränicher, G.; Babakjhani, M.; Göbel, S.; Jordan, I.; Marichal-Gallardo, P.; Genzel, Y.; Reichl, U.: A high cell density perfusion process for MVA virus production: process integration with inline DNA digestion and cost analysis. Authorea Preprints (2021)
Go to Editor View